Hofman P. ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice. Cancers (Basel). 2017;9: pubmed 出版商

Thunnissen E, Allen T, Adam J, Aisner D, Beasley M, Borczuk A, et al. Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society. Arch Pathol Lab Med. 2018;142:408-419 pubmed 出版商

Heydt C, Kostenko A, Merkelbach Bruse S, Wolf J, Buttner R. ALK evaluation in the world of multiplex testing: Network Genomic Medicine (NGM): the Cologne model for implementing personalised oncology. Ann Oncol. 2016;27 Suppl 3:iii25-iii34 pubmed 出版商

Wang Q, Zhao L, Yang X, Wei S, Zeng Y, Mao C, et al. Antibody 1A4 with routine immunohistochemistry demonstrates high sensitivity for ALK rearrangement screening of Chinese lung adenocarcinoma patients: A single-center large-scale study. Lung Cancer. 2016;95:39-43 pubmed 出版商

Li Y, Zhang R, Peng R, Ding J, Han Y, Wang G, et al. Reliability Assurance of Detection of EML4-ALK Rearrangement in Non-Small Cell Lung Cancer: The Results of Proficiency Testing in China. J Thorac Oncol. 2016;11:924-9 pubmed 出版商

von Laffert M, Schirmacher P, Warth A, Weichert W, Buttner R, Huber R, et al. [Statement of the German Society for Pathology and the working group thoracic oncology of the working group oncology/German Cancer Society on ALK testing in NSCLC: Immunohistochemistry and/or FISH?]. Pathologe. 2016;37:187-91 pubmed 出版商

von Laffert M, Schirmacher P, Warth A, Weichert W, Büttner R, Huber R, et al. [ALK-Diagnostics in NSCLC - Immunohistochemistry (IHC) and/or Fluorescence-in-situ Hybridisation (FISH)]. Pneumologie. 2016;70:277-81 pubmed 出版商

Collin M, Charles A, Barker A, Khosa J, Samnakay N. Inflammatory myofibroblastic tumour of the bladder in children: a review. J Pediatr Urol. 2015;11:239-45 pubmed 出版商

Gruber K, Kohlhäufl M, Friedel G, Ott G, Kalla C. A novel, highly sensitive ALK antibody 1A4 facilitates effective screening for ALK rearrangements in lung adenocarcinomas by standard immunohistochemistry. J Thorac Oncol. 2015;10:713-6 pubmed 出版商

Wang Q, He Y, Yang X, Wang Y, Xiao H. Extraordinary response to crizotinib in a woman with squamous cell lung cancer after two courses of failed chemotherapy. BMC Pulm Med. 2014;14:83 pubmed 出版商